cancer antigen 125 (CA-125) antibody and antigen (Recombinant protein)
Diagnostic cancer antigen 125 (CA-125) antibodies (anti-cancer antigen 125, anti-CA-125) and antigens (recombinant cancer antigen 125 (CA-125) protein) for Cancer CA-125 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-CA-125-Ag01 | Recombinant human MUC16/CA-125/CA125 Protein | 3090 |
GMP-h-CA-125-Ab01 | Anti-human MUC16/CA-125/CA125 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-CA-125-Ab02 | Anti-human MUC16/CA-125/CA125 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-CA-125-Ab03 | Anti-human MUC16/CA-125/CA125 human monoclonal antibody (mAb) | 1953 |
GMP-h-CA-125-Ab04 | Anti-human MUC16/CA-125/CA125 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-CA-125-Ag01 |
Product Name | Recombinant human MUC16/CA-125/CA125 Protein |
Target/Biomarker | cancer antigen 125(CA-125) |
Alias of Target/Biomarker | CA125 |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | cancer antigen 125 (CA-125) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA-125 level test of Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome evaluation. |
Products description | Recombinant human MUC16/CA-125/CA125 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-CA-125-Ab01, GMP-h-CA-125-Ab02 |
Product Name | Anti-human MUC16/CA-125/CA125 mouse monoclonal antibody (mAb) |
Target/Biomarker | cancer antigen 125(CA-125) |
Alias of Target/Biomarker | CA125 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human cancer antigen 125 (CA-125) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cancer antigen 125 (CA-125) antibodies in CA-125 level test of Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human MUC16/CA-125/CA125 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-CA-125-Ab03, GMP-h-CA-125-Ab04 |
Product Name | Anti-human MUC16/CA-125/CA125 human monoclonal antibody (mAb) |
Target/Biomarker | cancer antigen 125(CA-125) |
Alias of Target/Biomarker | CA125 |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human cancer antigen 125 (CA-125) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other cancer antigen 125 (CA-125) antibodies in CA-125 level test of Cancer (ovarian, endometrial, peritoneal and fallopian tube cancers.) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human MUC16/CA-125/CA125 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
The serum biomarker cancer antigen 125 (CA125) is widely used as an investigation for possible ovarian cancer in symptomatic women presenting to primary care. A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in your blood. A CA 125 test may be used to monitor certain cancers during and after treatment. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease. A CA 125 test isn't accurate enough to use for ovarian cancer screening in general because many noncancerous conditions can increase the CA 125 level. Many different conditions can cause an increase in CA 125, including normal conditions, such as menstruation, and noncancerous conditions, such as uterine fibroids. Certain cancers may also cause an increased level of CA 125, including ovarian, endometrial, peritoneal and fallopian tube cancers.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments